OSIS (OSI Systems Inc)
Insider Trading Activity
Every open-market purchase and sale reported by OSIS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-26 | Michael Tropeano | PRESIDENT, RAPISCAN SYSTEMS | MIXED | — | — |
| 2026-08-26 | Cary M. Okawa | CHIEF ACCOUNTING OFFICER | MIXED | — | — |
| 2026-08-26 | VICTOR S SZE | GENERAL COUNSEL | MIXED | — | — |
| 2026-08-26 | Paul Keith Morben | PRES., OPTOELECTRONICS DIV | MIXED | — | — |
| 2026-08-25 | DEEPAK CHOPRA | Director | MIXED | — | — |
| 2026-08-25 | Glenn Grindstaff | CHIEF HUMAN RESOURCES OFFICER | MIXED | — | — |
| 2026-08-25 | Cary M. Okawa | CHIEF ACCOUNTING OFFICER | F | — | — |
| 2026-08-25 | AJAY MEHRA | PRESIDENT AND CEO | MIXED | — | — |
| 2026-08-25 | ALAN I EDRICK | EVP & CFO | MIXED | — | — |
| 2026-08-21 | Kelli Bernard | Director | F | — | — |
| 2026-08-21 | DEEPAK CHOPRA | Director | F | — | — |
| 2026-08-21 | GERALD M CHIZEVER | Director | F | — | — |
| 2026-08-21 | JAMES B HAWKINS | Director | F | — | — |
| 2026-08-17 | Kelli Bernard | Director | F | — | — |
| 2026-08-17 | GERALD M CHIZEVER | Director | F | — | — |
| 2026-08-17 | JAMES B HAWKINS | Director | F | — | — |
| 2026-08-04 | Paul Keith Morben | PRES., OPTOELECTRONICS DIV | A | — | — |
| 2026-08-04 | Glenn Grindstaff | CHIEF HUMAN RESOURCES OFFICER | A | — | — |
| 2026-08-04 | Michael Tropeano | PRESIDENT, RAPISCAN SYSTEMS | A | — | — |
| 2026-08-04 | AJAY MEHRA | PRESIDENT AND CEO | A | — | — |
| 2026-08-04 | W Paul Constantine | PRES., SPACELABS HEALTHCARE | A | — | — |
| 2026-08-04 | ALAN I EDRICK | EVP & CFO | A | — | — |
| 2026-08-04 | Cary M. Okawa | CHIEF ACCOUNTING OFFICER | A | — | — |
| 2026-08-04 | VICTOR S SZE | GENERAL COUNSEL | A | — | — |
| 2026-07-29 | JAMES B HAWKINS | Director | F | — | — |
| 2026-07-29 | Kelli Bernard | Director | F | — | — |
| 2026-07-29 | GERALD M CHIZEVER | Director | F | — | — |
| 2026-07-21 | JAMES B HAWKINS | Director | A | — | — |
| 2026-07-21 | DEEPAK CHOPRA | Director | A | — | — |
| 2026-07-21 | William Francis Ballhaus JR | Director | A | — | — |
| 2026-07-21 | GERALD M CHIZEVER | Director | A | — | — |
| 2026-07-21 | Kelli Bernard | Director | A | — | — |
| 2026-07-07 | JAMES B HAWKINS | Director | F | — | — |
| 2026-07-07 | Kelli Bernard | Director | F | — | — |
| 2026-07-07 | GERALD M CHIZEVER | Director | F | — | — |
| 2026-07-01 | ALAN I EDRICK | EVP & CFO | A | — | — |
| 2026-07-01 | Cary M. Okawa | CHIEF ACCOUNTING OFFICER | A | — | — |
| 2026-07-01 | W Paul Constantine | PRES., SPACELABS HEALTHCARE | A | — | — |
| 2026-07-01 | Paul Keith Morben | PRES., OPTOELECTRONICS DIV | A | — | — |
| 2026-07-01 | Michael Tropeano | PRESIDENT, RAPISCAN SYSTEMS | A | — | — |
| 2026-07-01 | Glenn Grindstaff | CHIEF HUMAN RESOURCES OFFICER | A | — | — |
| 2026-07-01 | VICTOR S SZE | GENERAL COUNSEL | A | — | — |
| 2026-07-01 | AJAY MEHRA | PRESIDENT AND CEO | A | — | — |
| 2026-05-05 | DEEPAK CHOPRA | Director | Sell | — | — |
| 2026-04-24 | W Paul Constantine | PRES., SPACELABS HEALTHCARE | F | — | — |
| 2026-02-04 | DEEPAK CHOPRA | Director | Sell | — | — |
| 2026-01-02 | Michael Tropeano | PRESIDENT, RAPISCAN SYSTEMS | A | — | — |
| 2026-01-02 | Cary M. Okawa | CHIEF ACCOUNTING OFFICER | A | — | — |
| 2026-01-02 | ALAN I EDRICK | EVP & CFO | A | — | — |
| 2026-01-02 | DEEPAK CHOPRA | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | EVP & CFO | 306,538 | — |
| — | Director | 274,218 | — |
| — | GENERAL COUNSEL | 115,994 | — |
| — | PRESIDENT AND CEO | 115,578 | — |
| — | PRES., OPTOELECTRONICS DIV | 109,356 | — |
| — | Pres., Spacelabs Healthcare | 57,112 | — |
| — | Director | 33,188 | — |
| — | Director | 29,475 | — |
| — | Director | 20,388 | — |
| — | — | 17,060 | — |
| — | Director | 16,271 | — |
| — | Director | 15,410 | — |
| — | SVP, Chief HR Officer | 14,861 | — |
| — | PRES., RAPISCAN SYSTEMS | 12,628 | — |
| — | PRES., OPTOELECTRONICS DIV | 11,386 | — |
| — | Pres., Rapiscan Systems | 11,037 | — |
| — | Director | 10,781 | — |
| — | Director | 10,447 | — |
| — | CHIEF HUMAN RESOURCES OFFICER | 10,193 | — |
| — | PRES., SPACELABS HEALTHCARE | 9,298 | — |
| — | Director | 7,688 | — |
| — | Pres., Spacelabs Healthcare | 7,375 | — |
| — | Director | 5,295 | — |
| — | PRESIDENT, RAPISCAN SYSTEMS | 5,003 | — |
| — | President, OSI Electronics | 4,385 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the OSIS quote page; the site-wide leaderboard is on the insider transactions hub.